Anemia Management in Acute Gastrointestinal Bleeding
Restrictive red blood cell (RBC) transfusion strategies are recommended for most hemodynamically stable patients with acute GI bleeding. [1], [2]
Intravenous iron replacement is recommended after stabilization when iron deficiency is present or strongly suspected. [3], [4]
Initial Assessment and Diagnostic Priorities
Hemoglobin should be measured at presentation and reassessed after resuscitation and during ongoing bleeding evaluation. [1]
Iron deficiency evaluation (ferritin, transferrin saturation, and reticulocyte response) should be performed after hemodynamic stabilization and when clinically feasible. [4]
Transfusion decisions should be based on clinical context, including hemodynamic stability and cardiovascular comorbidity, rather than hemoglobin level alone. [1]
RBC Transfusion Strategy
A restrictive RBC transfusion threshold is suggested for nonvariceal upper GI bleeding. [1]
For acute nonvariceal UGIB without cardiovascular disease, the suggested hemoglobin threshold for transfusion is < 80 g/L (<8.0 g/dL). [1]
For acute UGIB with cardiovascular disease, a higher transfusion threshold is suggested. [1]
For hemodynamically stable acute upper GI hemorrhage without cardiovascular disease, ESGE recommends transfusion when hemoglobin is ≤70 g/L (≤7.0 g/dL), targeting post-transfusion hemoglobin 70–90 g/L (7.0–9.0 g/dL). [2]
Iron Replacement Strategy After Stabilization
Iron deficiency should be treated after bleeding stabilization to restore iron stores and reduce recurrent anemia risk. [3], [4]
Intravenous (IV) iron is favored over oral iron when rapid repletion is needed, oral iron is not tolerated, or oral absorption is unlikely to meet repletion requirements. [3], [4]
IV iron formulations used in GI bleeding and iron repletion include ferric carboxymaltose and iron sucrose. [3], [4]
Monotherapy Versus Combination Therapy
RBC transfusion and iron replacement should be treated as complementary strategies. [4]
RBC transfusion provides immediate oxygen-carrying capacity, while IV iron provides substrate for hematopoietic recovery after bleeding control. [3], [4]
IV iron should not replace the need for RBC transfusion when transfusion thresholds and clinical status indicate immediate correction of anemia. [4]
Important Clarifications and Nuances
Transfusion thresholds are lower in patients without cardiovascular disease and higher in patients with cardiovascular comorbidity. [1], [2]
Hemoglobin-based decisions should be integrated with clinical status because ongoing bleeding, hemodynamic instability, and symptoms can warrant intervention despite restrictive thresholds. [4]
Common Pitfalls to Avoid
Giving transfusions without reassessment after each unit increases avoidable exposure. [4]
Deferring iron repletion until after hematologic recovery increases the duration of iron deficiency-related anemia. [3]
Target Hematologic Goals
For restrictive strategies in hemodynamically stable acute upper GI hemorrhage without cardiovascular disease, post-transfusion hemoglobin targeting 70–90 g/L (7.0–9.0 g/dL) is recommended. [2]
For nonvariceal UGIB, the suggested transfusion threshold is <8.0 g/dL in patients without cardiovascular disease, with individualized higher thresholds when cardiovascular disease is present. [1]